LIGAND PHARMACEUTICALS INC Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LIGAND PHARMACEUTICALS INC for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Option Exercise | A | 85.79 | 55,391 | 4,751,994 | 55,391 | |
| Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Payment of Exercise | F | 85.97 | 2,492 | 214,237 | 130,497 | 133 K to 130.5 K (-1.87 %) |
| Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Grant | A | 0.00 | 11,611 | 0 | 132,989 | 121.4 K to 133 K (+9.57 %) |
| Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | A | 85.79 | 27,080 | 2,323,193 | 27,080 | |
| Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 85.97 | 1,642 | 141,163 | 76,662 | 78.3 K to 76.7 K (-2.10 %) |
| Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 5,676 | 0 | 78,304 | 72.6 K to 78.3 K (+7.82 %) |
| Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | VP, Finance and CFO | Option Exercise | A | 85.79 | 18,464 | 1,584,027 | 18,464 | |
| Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | VP, Finance and CFO | Grant | A | 0.00 | 3,870 | 0 | 9,870 | 6 K to 9.9 K (+64.50 %) |
| Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 85.79 | 10,463 | 897,621 | 10,463 | |
| Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Grant | A | 0.00 | 2,193 | 0 | 29,647 | 27.5 K to 29.6 K (+7.99 %) |
| Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | Herman Melanie J | Director of Account ... | Option Exercise | A | 85.79 | 5,000 | 428,950 | 5,000 | |
| Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | Herman Melanie J | Director of Account ... | Payment of Exercise | F | 85.97 | 160 | 13,755 | 3,631 | 3.8 K to 3.6 K (-4.22 %) |
| Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | Herman Melanie J | Director of Account ... | Grant | A | 0.00 | 500 | 0 | 3,791 | 3.3 K to 3.8 K (+15.19 %) |